Royalty Pharma plc

Contributing Author

Recent Articles by Royalty Pharma plc

Mar-02	Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform RPRX GlobeNewswire
Mar-02	Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing RPRX GlobeNewswire
Feb-26	Royalty Pharma to Present at TD Cowen's 46th Annual Health Care Conference RPRX GlobeNewswire
Feb-11	Royalty Pharma Reports Q4 and Full Year 2025 Results RPRX GlobeNewswire
Jan-20	Royalty Pharma to Announce Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026 RPRX GlobeNewswire
Jan-12	Royalty Pharma to Highlight Accomplishments and Provide Business Update at 44th Annual J.P. Morgan Healthcare Conference RPRX GlobeNewswire
Jan-11	Royalty Pharma and Teva Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo RPRX GlobeNewswire
Jan-09	Royalty Pharma Announces Dividend Increase RPRX GlobeNewswire
Dec-29	Royalty Pharma Acquires Remaining Royalty Interest in Roche's Evrysdi for $240 Million and Potential Milestones RPRX GlobeNewswire
Dec-16	Royalty Pharma Acquires Royalty Interest in Nuvalent's Neladalkib and Zidesamtinib for Up to $315 Million RPRX GlobeNewswire
Dec-04	Royalty Pharma and Denali Therapeutics Announce $275 Million Royalty Funding Agreement RPRX GlobeNewswire
Nov-26	Royalty Pharma to Present at Upcoming Investor Conferences RPRX GlobeNewswire
Nov-05	Royalty Pharma Reports Third Quarter 2025 Results RPRX +6.82% GlobeNewswire
Nov-04	Royalty Pharma Acquires Royalty Interest in Alnylam's AMVUTTRA for $310 Million from Blackstone Life Sciences RPRX GlobeNewswire
Oct-17	Royalty Pharma Declares Fourth Quarter 2025 Dividend RPRX GlobeNewswire
Oct-09	Royalty Pharma to Announce Third Quarter 2025 Financial Results on November 5, 2025 RPRX GlobeNewswire
Sep-29	Royalty Pharma Appoints Dr. Ted W. Love As Lead Independent Director RPRX GlobeNewswire
Sep-19	Royalty Pharma to Present at Bernstein's 2nd Annual Healthcare Forum RPRX GlobeNewswire
Sep-11	Royalty Pharma Investor Day Highlights Strong Growth Outlook and Company's Plans to Drive Value Creation RPRX GlobeNewswire
Sep-10	Royalty Pharma Announces Release of Deloitte's Report on the Biopharma Royalty Market RPRX GlobeNewswire
Sep-04	Royalty Pharma to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference RPRX GlobeNewswire
Sep-02	Royalty Pharma Announces Pricing of $2.0 Billion of Senior Unsecured Notes RPRX GlobeNewswire
Sep-02	Royalty Pharma and Zenas BioPharma Enter Into Obexelimab Funding Agreement for Up to $300 Million RPRX GlobeNewswire
Aug-25	Royalty Pharma to Acquire Royalty Interest in Amgen's Imdelltra for up to $950 Million RPRX GlobeNewswire
Aug-13	Henry Fernandez Steps Down from Royalty Pharma's Board of Directors RPRX GlobeNewswire
Aug-06	Royalty Pharma Reports Second Quarter 2025 Results RPRX GlobeNewswire
Jul-18	Royalty Pharma Declares Third Quarter 2025 Dividend RPRX GlobeNewswire
Jul-17	Royalty Pharma Appoints Carole Ho and Elizabeth Weatherman to the Company's Board of Directors RPRX GlobeNewswire
Jul-16	Royalty Pharma to Announce Second Quarter 2025 Financial Results on August 6, 2025 RPRX GlobeNewswire
Jun-24	Royalty Pharma and Revolution Medicines Enter Into Funding Agreements for Up to $2 Billion RPRX GlobeNewswire
Jun-04	Royalty Pharma to Present at the Goldman Sachs 46th Annual Global Healthcare Conference RPRX GlobeNewswire
May-16	Royalty Pharma Completes the Acquisition of Its External Manager RPRX GlobeNewswire
May-13	Royalty Pharma to Present at Upcoming Investor Conferences RPRX GlobeNewswire
May-12	Royalty Pharma Announces Shareholder Approval of its External Manager Acquisition RPRX GlobeNewswire
May-08	Royalty Pharma Reports First Quarter 2025 Results RPRX GlobeNewswire

Royalty Pharma plc

Recent Articles by Royalty Pharma plc

Upgrade your FINVIZ experience